Context Therapeutics
CNTX
CNTX
23 hedge funds and large institutions have $3.89M invested in Context Therapeutics in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
23
Holders Change
+1
Holders Change %
+4.55%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
DCM
1
Difesa Capital Management
New York
|
$0 |
| 2 |
2
Two Sigma Investments
New York
|
$0 |
| 3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$147K |